Showing results (91-100 of 220) with videos related to
Sort By:
Pageof 22
Journal of Neuroscience Research|September 6, 2001
Glial cell death induced by overexpression of alpha-synucleinN Stefanova, L Klimaschewski, W Poewe, et al.Journal of Neurology|May 8, 2002
Botulinum toxin treatment in atypical parkinsonian disorders associated with disabling focal dystoniaJ Müller, G K Wenning, J Wissel, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|July 6, 2005
How to diagnose MSA early: the role of magnetic resonance imagingK Seppi, M F H Schocke, G K Wenning, et al.Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
123I-beta-CIT and 123I-IBZM-SPECT scanning in levodopa-naive Parkinson's diseaseG K Wenning, E Donnemiller, R Granata, et al.Journal of Neural Transmission. Supplementum|May 21, 1999
Neural transplantation in animal models of multiple system atrophy: a reviewG K Wenning, R Granata, Z Puschban, et al.European Journal of Neurology|July 2, 2009
Botulinum toxin B increases mouth opening in patients with spastic trismusU M Fietzek, P Kossmehl, A Barthels, et al.Movement Disorders : Official Journal of the Movement Disorder Society|December 19, 2001
Rhythmic feet movements while falling asleepA Wichniak, F Tracik, P Geisler, et al.Journal of Neurology|January 1, 1992
Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patientsW Poewe, L Schelosky, B Kleedorfer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|December 1, 1985
Magnetic resonance imaging in the diagnosis of spinal cord diseasesF Aichner, W Poewe, W Rogalsky, et al.La Radiologia Medica|March 1, 1996
[Cerebral SPECT with iodine-123 IBZM in patients with extrapyramidal system disorders: the evaluation of its sensitivity in therapy with dopaminergic drugs]J Hierholzer, L Castelli, M Cordes, et al.Pageof 22